Aadi Bioscience's low P/S ratio may be due to its poor reven...
Aadi Bioscience's low P/S ratio may be due to its poor revenue outlook. Investors may believe the potential for revenue improvement doesn't justify a higher P/S ratio. These conditions could continue to limit the share price.
Aadi Bioscience, Inc.'s (NASDAQ:AADI) Shares Bounce 27% But Its Business Still Trails The Industry
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment